On this basis, it is conceivable that NK cells (ILC1) and other subsets of ILC (ILC2 and ILC3) are not only involved in the control of healthy gut but also in the pathogenesis and evolution of gut diseases, including inflammatory bowel disease (IBD) and colorectal carcinoma (CRC) (20–23). The gene discussed is CCL27; the disease is inflammatory bowel disease.